½ÃÀ庸°í¼­
»óǰÄÚµå
1526281

¼¼°èÀÇ ¿µ»ó Áø´Ü ½ÃÀå

Diagnostic Imaging

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Industry Analysts, Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 537 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¿µ»ó Áø´Ü ¼¼°è ½ÃÀåÀº 2030³â±îÁö 410¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2023³â¿¡ 290¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¿µ»ó Áø´Ü ¼¼°è ½ÃÀåÀº 2023-2030³â°£ CAGR 5.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 410¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ X¼± ¿µ»óÀº CAGR 4.5%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 94¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. MRI ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ CAGR·Î 5.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 88¾ï ´Þ·¯, Áß±¹Àº CAGR 7.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿µ»ó Áø´Ü ½ÃÀåÀº 2023³â¿¡ 88¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 52¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³â°£ CAGRÀº 7.2%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.2%¿Í 4.4%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.2%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°è ¿µ»ó Áø´Ü ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

¿µ»ó Áø´ÜÀº Çö´ë ÀÇÇп¡¼­ Áß¿äÇÑ µµ±¸·Î, ºñħ½ÀÀûÀ¸·Î ü³» ±¸Á¶¸¦ ½Ã°¢È­ÇÏ¿© Áúº´À» È¿°úÀûÀ¸·Î Áø´Ü, ¸ð´ÏÅ͸µ ¹× Ä¡·áÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀÌ ºÐ¾ß¿¡´Â ¿¢½º·¹ÀÌ, ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CT), ÀÚ±â°ø¸í¿µ»ó(MRI), ÃÊÀ½ÆÄ, ¾çÀüÀÚ¹æ»ç¼±´ÜÃþÃÔ¿µ(PET) ¹× ´ÜÀϱ¤ÀÚ¹æ»ç¼±´ÜÃþÃÔ¿µ(SPECT)À» Æ÷ÇÔÇÑ ÇÙÀÇÇÐ µî ´Ù¾çÇÑ ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ °Ë»ç¹ýÀº °¢°¢ ¶Ñ·ÇÇÑ ¸ñÀûÀ» °¡Áö°í ÀÖÀ¸¸ç, ƯÁ¤ ÁúȯÀ̳ª °Ë»ç ºÎÀ§¿¡ µû¶ó ¼±Åõ˴ϴÙ. ¿¹¸¦ µé¾î, ¿¢½º·¹ÀÌ´Â »À¸¦ º¸°Å³ª °ñÀýÀ» ¹ß°ßÇÏ´Â µ¥ ÁÖ·Î »ç¿ëµÇÁö¸¸, ¿¬ºÎÁ¶Á÷Àº MRI°¡ ´õ Àß º¼ ¼ö ÀÖ½À´Ï´Ù. ÃÊÀ½ÆÄ °Ë»ç´Â »êºÎÀΰú¿Í ½ÉÀåÇп¡¼­ ÀӽŠÁß Å¾Ƹ¦ °Ë»çÇϰųª ½ÉÀå ±â´ÉÀ» Æò°¡ÇÏ´Â µ¥ ÀÚÁÖ »ç¿ëµË´Ï´Ù. ÇÙÀÇÇÐÀº ÀÎü¿¡ ´ëÇÑ ±â´ÉÀû Á¤º¸¸¦ Á¦°øÇÏ°í ºÐÀÚ È°µ¿À» °¨ÁöÇÏ¿© ´Ù¸¥ ¿µ»ó °Ë»ç·Î ¹àÇôÁö±â Àü¿¡ Áúº´À» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¿µ»ó Áø´ÜÀÇ ´É·ÂÀ» ºñ¾àÀûÀ¸·Î Çâ»ó½ÃÄ×½À´Ï´Ù. µðÁöÅÐ À̹ÌÁö ¹× 3D À籸¼º µîÀÇ ±â¼ú Çõ½ÅÀ¸·Î À̹ÌÁö ǰÁúÀÌ Çâ»óµÇ°í ¹æ»ç¼± ÇÇÆøÀÌ °¨¼ÒÇß½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ¿µ»ó ó¸® ±â¼úÀÇ ÅëÇÕÀº ÀÌ ºÐ¾ß¿¡ º¯È­¸¦ °¡Á®¿ÔÀ¸¸ç, AI ¾Ë°í¸®ÁòÀº Àΰ£ÀÇ ´«À¸·Î´Â ³õÄ¥ ¼ö ÀÖ´Â ÆÐÅÏÀ» °¨ÁöÇÏ¿© ¿µ»óÀÇÇаú Àǻ簡 ¾Ï°ú °°Àº Áúº´À» º¸´Ù È¿°úÀûÀ¸·Î Áø´ÜÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÈÞ´ë¿ë ¿µ»ó Áø´Ü ÀåºñÀÇ °³¹ß·Î Áø´Ü ¼­ºñ½ºÀÇ ¹üÀ§°¡ È®´ëµÇ¾î ÀÀ±Þ »óȲÀ̳ª ³óÃÌ ¹× ÀÚ¿øÀÌ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ ƯÈ÷ °¡Ä¡ ÀÖ´Â ÇöÀå Áø·á ¼­ºñ½º¸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù¼º Çâ»óÀº Àû½Ã¿¡ Áø´Ü°ú Ä¡·á¿¡ ÇʼöÀûÀ̸ç ȯÀÚ °á°ú¿¡ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¶ÇÇÑ PET/CT ¹× PET/MRI¿Í °°Àº ÇÏÀ̺긮µå ¿µ»ó Áø´Ü ±â¼úÀÇ ¹ßÀüÀ¸·Î ÇØºÎÇÐÀû ±â´É°ú »ýÈ­ÇÐÀû ±â´ÉÀ» µ¿½Ã¿¡ ¿µ»óÈ­ÇÒ ¼ö ÀÖ°Ô µÇ¾î º¸´Ù Á¾ÇÕÀûÀÎ Æò°¡°¡ °¡´ÉÇØÁ® Áúº´ÀÇ Á¤È®ÇÑ ½Äº°°ú °ü¸®¿¡ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¿µ»ó Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀº ¼¼°è Àα¸ÀÇ °í·ÉÈ­, ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ¿µ»ó Áø´Ü ±â¼úÀÇ ¹ßÀü, ÀÇ·áºñ ÁöÃâ Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. Àα¸ °í·ÉÈ­¿Í ÇÔ²² ½ÉÇ÷°ü Áúȯ, ¾Ï, ½Å°æ Àå¾Ö¿Í °°Àº Áúº´ÀÇ ¹ß»ý·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ ¸ðµç Áúº´À» È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§Çؼ­´Â ¿µ»ó Áø´ÜÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¸¸¼º Áúȯ ¶ÇÇÑ ¸ðµç ¿¬·ÉÃþ¿¡¼­ ÈçÇØÁö°í ÀÖÀ¸¸ç, ÀæÀº ¸ð´ÏÅ͸µ°ú Æò°¡°¡ ÇÊ¿äÇØ ¿µ»ó Áø´Ü ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀº ¿µ»ó Áø´ÜÀÇ Ç°Áú°ú È¿À²¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ±× Àû¿ë ¹üÀ§¸¦ È®ÀåÇÏ°í ´õ ±¤¹üÀ§ÇÑ ÀÓ»ó µµÀÔÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀº ¿¹¹æ ÀÇ·á¿Í Á¶±â Áø´Ü¿¡ ´õ¿í ÁýÁßÇϰí ÀÖÀ¸¸ç, À̴ ÷´Ü ¿µ»ó ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï±¹À» Áß½ÉÀ¸·Î ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí, ÇÏÀ̺긮µå ¹× ÷´Ü ¿µ»ó Áø´Ü ¹æ½ÄÀÌ Á¡Â÷ ¼ö¿ëµÇ°í ÀÖ´Â °Íµµ ÀÌ ½ÃÀåÀÇ °ßÁ¶ÇÑ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌó·³ ¿µ»ó Áø´ÜÀº Çö´ë ÀÇ·á¿¡ ¾ø¾î¼­´Â ¾È µÉ Çʼö ¿ä¼Ò·Î ÀÚ¸®¸Å±èÇϰí ÀÖÀ¸¸ç, Áö¼ÓÀûÀÎ Çõ½ÅÀ» ÅëÇØ ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ ÀÖ¾î ±× ¿ªÇÒÀÌ ´õ¿í È®´ëµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 66°Ç)

  • Barco NV
  • Agfa-Gevaert NV
  • Analogic Corporation
  • Brainlab AG
  • Adelaide Health Care
  • Bracco Diagnostics, Inc.
  • Accuray, Inc.
  • Bracco SpA
  • Biodex Medical Systems, Inc.
  • Brain Scientific Inc.
  • Alliance Medical Limited
  • Asahi Roentgen Ind. Co., Ltd.
  • A. Menarini Asia-Pacific Holdings Pte., Ltd.
  • Beijing Wandong Medical Technology Co., Ltd.
  • Bonraybio Company Limited

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä
  • ¹Ý·Áµ¿¹°
  • ÁÖ¿ä ±â¾÷
  • ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
  • SPECT-CT
  • ¼¼°è ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ºÐ¼®

  • ¹Ì±¹
  • ij³ª´Ù
  • ÀϺ»
  • Áß±¹
  • À¯·´
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ¿µ±¹
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • È£ÁÖ
  • Àεµ
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • À̶õ
  • À̽º¶ó¿¤
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦4Àå °æÀï

LSH 24.08.09

Global Diagnostic Imaging Market to Reach US$41.0 Billion by 2030

The global market for Diagnostic Imaging estimated at US$29.0 Billion in the year 2023, is expected to reach US$41.0 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. X-ray Imaging, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$9.4 Billion by the end of the analysis period. Growth in the MRI segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.8 Billion While China is Forecast to Grow at 7.2% CAGR

The Diagnostic Imaging market in the U.S. is estimated at US$8.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Diagnostic Imaging Market - Key Trends & Drivers Summarized

Diagnostic imaging is a critical tool in modern medicine, enabling the visualization of the internal structures of the body non-invasively to diagnose, monitor, and treat medical conditions effectively. This field includes a variety of techniques such as X-ray radiography, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and nuclear medicine including positron emission tomography (PET) and single-photon emission computed tomography (SPECT). Each of these modalities serves distinct purposes and is chosen based on the specific medical conditions and the part of the body being examined. For instance, X-rays are often used for viewing bones and detecting fractures, while soft tissues are better visualized by MRI. Ultrasound is frequently used in obstetrics and cardiology to examine the fetus during pregnancy and assess cardiac functions. Nuclear medicine provides functional information about a person’s body, detecting molecular activity and can pinpoint disease in its earliest stages before they are apparent with other imaging tests.

Technological advancements have vastly improved the capabilities of diagnostic imaging. Innovations such as digital imaging and 3D reconstruction have enhanced image quality and reduced exposure to radiation. The integration of artificial intelligence (AI) with imaging technologies is transforming the field, enabling faster and more accurate analyses of images. AI algorithms help in detecting patterns that may be missed by the human eye, assisting radiologists in diagnosing diseases such as cancer more effectively. Furthermore, the development of portable imaging devices has expanded the reach of diagnostic services, allowing for point-of-care services that are particularly valuable in emergency settings and in rural or under-resourced areas. This accessibility improvement is vital for timely diagnosis and treatment, significantly impacting patient outcomes. Additionally, advances in hybrid imaging techniques, such as PET/CT and PET/MRI, allow for simultaneous imaging of anatomical and biochemical functions, providing a more comprehensive assessment and aiding in precise disease localization and management.

The growth in the diagnostic imaging market is driven by several factors, including the aging global population, the rising prevalence of chronic diseases, technological advancements in imaging modalities, and increasing healthcare expenditure. As the population ages, there is a higher incidence of conditions such as cardiovascular diseases, cancers, and neurological disorders, all of which require diagnostic imaging for effective management. Chronic diseases are also becoming more common across all age groups, necessitating frequent monitoring and evaluation, which supports the demand for imaging services. Technological advancements not only enhance the quality and efficiency of diagnostic imaging but also expand its applications, leading to broader clinical adoption. Additionally, healthcare systems worldwide are focusing more on preventive care and early diagnosis, which further drives the demand for advanced imaging solutions. The increasing investment in healthcare infrastructure, especially in emerging economies, and the growing acceptance of hybrid and advanced imaging modalities contribute to the robust growth of this market. Thus, diagnostic imaging continues to be an indispensable part of modern medical practice, with ongoing innovations ensuring its expanding role in healthcare delivery.

Select Competitors (Total 66 Featured) -

  • Barco NV
  • Agfa-Gevaert NV
  • Analogic Corporation
  • Brainlab AG
  • Adelaide Health Care
  • Bracco Diagnostics, Inc.
  • Accuray, Inc.
  • Bracco SpA
  • Biodex Medical Systems, Inc.
  • Brain Scientific Inc.
  • Alliance Medical Limited
  • Asahi Roentgen Ind. Co., Ltd.
  • A. Menarini Asia-Pacific Holdings Pte., Ltd.
  • Beijing Wandong Medical Technology Co., Ltd.
  • Bonraybio Company Limited

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Diagnostic Imaging - A Prelude
    • Global Diagnostic Imaging Market Set for a Strong Growth
    • Developed Regions: The Dominant Markets for Diagnostic Imaging
    • Developing Regions Exhibit the Fastest Growth
    • Increase in Number of Hospitals & Clinics Infuses Momentum in Developing Regions
    • Key Players
    • Diagnostic Imaging - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Segment Analysis
    • MRI Dominates the Global Diagnostic Imaging Market
    • Computed Tomography System (CT Scanner)
    • Ultrasound
    • X-Ray
    • Nuclear Medicine
    • SPECT Dominates the Nuclear Medicine Market
  • PET
  • 2. FOCUS ON SELECT PLAYERS
    • Agfa-Gevaert N.V. (Belgium
    • Canon Medical Systems Corporation (Japan)
    • Carestream Health, Inc. (USA)
    • Esaote S.p.A. (Italy)
    • Fujifilm Corporation (Japan)
    • GE Healthcare (UK)
    • Koninklijke Philips N.V. (Netherlands)
    • Konica Minolta Inc. (Japan)
    • Hitachi Ltd. (Japan)
    • Hologic, Inc. (USA)
    • HOYA Group Pentax (Japan)
    • Samsung Medison Co., Ltd. (Korea)
    • Shimadzu Corporation (Japan)
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China
    • Siemens Healthineers (Germany)
  • 3. MARKET TRENDS & DRIVERS
    • Rapidly Growing Geriatric Population and the Rise in Associated Diseases Catalyze Growth
    • Rapidly Aging Population Spurs Demand for Diagnostic Imaging: Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020, 2025, 2030 & 2050
    • Rising Incidence of Chronic Diseases Propels the Demand for Medical Imaging
    • Rising Prevalence of Chronic Diseases Amplifies the Volume of Diagnostic Imaging Procedures: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
    • Growing Emphasis on Early Diagnosis is a Driving Factor for Diagnostic Imaging
    • Rising Healthcare Expenditure Impels Global Market
    • Oncology Diagnostic Imaging to Witness Rapid Growth
    • Technological Innovations Drive the Global Diagnostic Imaging Market
    • Growing Adoption of Hybrid Diagnostic Imaging Modalities
    • PET-CT: The Most Successful Fusion Imaging Technique
  • SPECT-CT
    • PET/MRI Continues to Makes Inroads
    • Ultrasound and MRI Imaging: An Efficient Combination
    • Rapid Adoption of Contrast-Enhanced Ultrasound (CEUS) Drives Market Growth
    • CT Imaging Gains Popularity
    • CCTA Gaining Traction in Coronary Arteries Imaging
    • Use of Blockchain in Diagnostic Imaging
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Diagnostic Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Diagnostic Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for X-ray Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for X-ray Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for X-ray Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Nuclear Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Diagnostic Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Diagnostic Imaging Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Diagnostic Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Diagnostic Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Diagnostic Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Diagnostic Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Diagnostic Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Diagnostic Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Diagnostic Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Diagnostic Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦